[go: up one dir, main page]

CO5550416A2 - Compuestos surfactantes y usos de los mismos - Google Patents

Compuestos surfactantes y usos de los mismos

Info

Publication number
CO5550416A2
CO5550416A2 CO04008339A CO04008339A CO5550416A2 CO 5550416 A2 CO5550416 A2 CO 5550416A2 CO 04008339 A CO04008339 A CO 04008339A CO 04008339 A CO04008339 A CO 04008339A CO 5550416 A2 CO5550416 A2 CO 5550416A2
Authority
CO
Colombia
Prior art keywords
fluoroalkyl
surfacting
compounds
same
formula
Prior art date
Application number
CO04008339A
Other languages
English (en)
Inventor
Istvan Kaldor
Brian Edgar Looker
Christopher James Lunniss
Alison Judith Redgrave
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0118994A external-priority patent/GB0118994D0/en
Priority claimed from GB0206892A external-priority patent/GB0206892D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CO5550416A2 publication Critical patent/CO5550416A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • C07C59/135—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/63—Halogen-containing esters of saturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708—Ethers
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00—Materials not provided for elsewhere
    • C09K3/30—Materials not provided for elsewhere for aerosols

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Materials Engineering (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

1.- Una formulación de aerosol farmacéutica que comprende un compuesto de la fórmula general (la) o una sal o solvato del mismo, en donde:m representa un número entero en el rango de 1 a 16; yR1a representa fluoroalquil C1-4 alquileno C0-6- o fluoroalquil C1-4 alquileno C0-6-O- en donde cada porción de fluoroalquil C1-4 contiene uno o más átomos de flúor pero no más de 3 átomos de carbono perfluorinados consecutivos.10.- Un compuesto de la fórmula (la) según la reivindicación 1 que tiene la fórmula (Iaa)o una sal o solvato del mismo, en donde:m representa un número entero de 1 a 16; yR1aa representa CF3 o CF3CF2.en donde cuando R1aa representa CF3, m es 7 a 9 u 11 a 15.
CO04008339A 2001-08-03 2004-02-03 Compuestos surfactantes y usos de los mismos CO5550416A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0118994A GB0118994D0 (en) 2001-08-03 2001-08-03 Compounds
GB0206892A GB0206892D0 (en) 2002-03-23 2002-03-23 Compounds

Publications (1)

Publication Number Publication Date
CO5550416A2 true CO5550416A2 (es) 2005-08-31

Family

ID=26246403

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04008339A CO5550416A2 (es) 2001-08-03 2004-02-03 Compuestos surfactantes y usos de los mismos

Country Status (20)

Country Link
US (1) US7195752B2 (es)
EP (2) EP1411896B1 (es)
JP (2) JP2005501082A (es)
KR (1) KR20040025738A (es)
CN (1) CN1279893C (es)
AT (2) ATE320795T1 (es)
AU (1) AU2002321422B2 (es)
BR (1) BR0211656A (es)
CA (1) CA2456052A1 (es)
CO (1) CO5550416A2 (es)
DE (2) DE60222591T2 (es)
ES (2) ES2260468T3 (es)
HU (1) HUP0401194A2 (es)
IL (1) IL160114A0 (es)
MX (1) MXPA04001049A (es)
NO (1) NO20040462L (es)
NZ (1) NZ530828A (es)
PL (1) PL368805A1 (es)
RU (1) RU2004103075A (es)
WO (1) WO2003013610A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0125127D0 (en) 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds
BR0306976A (pt) 2002-02-13 2004-12-14 Glaxo Group Ltd Composto, formulação de aerossol farmacêutica, inalador de dose medida, uso de uma formulação, uso de um composto, e, processo para a preparação dos compostos
GB0323701D0 (en) * 2003-10-09 2003-11-12 Glaxo Group Ltd Formulations
WO2005099718A1 (en) * 2004-04-19 2005-10-27 Centre National De La Recherche Scientifique (C.N.R.S.) Lung surfactant supplements
CA2575297C (en) 2004-08-04 2014-09-23 Acea Biosciences, Inc. Method for assaying for natural killer, cytotoxic t-lymphocyte and neutrophil-mediated killing of target cells using real-time microelectronic cell sensing technology
DE102005000858A1 (de) * 2005-01-05 2006-07-20 Merck Patent Gmbh Fluortenside
PL240578B1 (pl) * 2018-10-26 2022-05-02 Nanosanguis Związek chemiczny będący solą amoniową częściowo fluorowanych kwasów organicznych oraz jego zastosowania

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3250808A (en) * 1963-10-31 1966-05-10 Du Pont Fluorocarbon ethers derived from hexafluoropropylene epoxide
US3498923A (en) * 1966-10-18 1970-03-03 Us Navy Surface-active compositions and method for displacing liquid organic films from solid surfaces
JPS5331582A (en) 1976-09-04 1978-03-24 Daikin Ind Ltd Aerosol composition
US4346235A (en) * 1979-06-15 1982-08-24 Okamura Oil Mill Limited Fluorine-containing compounds
JPS62297478A (ja) 1986-06-18 1987-12-24 Nippon Soda Co Ltd 表面処理剤およびその製造方法
FR2613357B1 (fr) * 1987-04-06 1989-06-16 Atochem Trifluoromethylation de composes organiques insatures
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
CA2077354A1 (en) * 1990-03-23 1991-09-24 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
PT98105B (pt) * 1990-06-28 1998-11-30 Glaxo Inc Processo para a preparacao de formulacoes em aerossol contendo como propulsor 1,1,1,2-tetrafluoroetano
JPH04283538A (ja) 1991-03-13 1992-10-08 Neos Co Ltd 含フッ素カルボン酸誘導体
JP2668760B2 (ja) 1992-06-02 1997-10-27 スカイアルミニウム 株式会社 アルカリ化学粗面化用アルミニウム合金展伸材およびその製造方法
GB9419536D0 (en) * 1994-09-28 1994-11-16 Glaxo Inc Medicaments
DE19603033A1 (de) 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19608278A1 (de) * 1996-02-23 1997-08-28 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie
DE19731300C1 (de) 1997-07-11 1999-01-21 Schering Ag Perfluoralkylgruppenhaltige Trijodaromaten, Verfahren zu deren Herstellung und deren Verwendung als Kontrastmittel
DE19731591C2 (de) 1997-07-17 1999-09-16 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylgruppenhaltige Trijodaromaten und ihre Verwendung in der Tumortherapie und interventionellen Radiologie
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers

Also Published As

Publication number Publication date
WO2003013610A3 (en) 2003-10-30
WO2003013610A2 (en) 2003-02-20
PL368805A1 (en) 2005-04-04
US7195752B2 (en) 2007-03-27
CN1279893C (zh) 2006-10-18
EP1486203A2 (en) 2004-12-15
NO20040462L (no) 2004-03-23
AU2002321422B2 (en) 2006-05-25
DE60222591T2 (de) 2008-06-19
EP1411896B1 (en) 2006-03-22
RU2004103075A (ru) 2005-04-20
HUP0401194A2 (hu) 2004-11-29
ATE373469T1 (de) 2007-10-15
CN1561198A (zh) 2005-01-05
DE60210102D1 (de) 2006-05-11
EP1411896A2 (en) 2004-04-28
EP1486203A3 (en) 2005-03-16
BR0211656A (pt) 2004-07-13
JP2005501082A (ja) 2005-01-13
ES2260468T3 (es) 2006-11-01
ATE320795T1 (de) 2006-04-15
NZ530828A (en) 2005-10-28
KR20040025738A (ko) 2004-03-25
US20040234556A1 (en) 2004-11-25
DE60222591D1 (de) 2007-10-31
IL160114A0 (en) 2004-06-20
ES2293157T3 (es) 2008-03-16
DE60210102T2 (de) 2006-08-31
MXPA04001049A (es) 2004-05-20
CA2456052A1 (en) 2003-02-20
EP1486203B1 (en) 2007-09-19
JP2006008695A (ja) 2006-01-12

Similar Documents

Publication Publication Date Title
SV2003000617A (es) Inhibidores de la proteasa peptidomimetica ref. x-14912m
ES2052881T3 (es) Agentes reductores de la presion sanguinea.
ES2065701T3 (es) Furoato de mometasona monohidrato, procedimiento para fabricar el mismo y composiciones farmaceuticas.
AR077416A2 (es) Compuesto polimorfo estable de flibanserina , procedimiento industrial para su preparacion y uso del mismo para preparar medicamentos
ES2137524T3 (es) Emulsiones de fluorocarbono estables inversas y multiples.
AR005053A1 (es) Compuestos de difenilhexano, un procedimiento para su preparacion, composiciones farmaceuticas y el uso de dichos compuestos, y procedmientos para la manufactura de medicamentos para inhibir la infeccion de hiv
AR051778A2 (es) Derivados del acido dimetilaminocrotonico y procesos para supreparacion
ES2097409T3 (es) Benzoilguanidinas, procedimiento para su preparacion, asi como su empleo como antiarritmicos.
ES2099047T1 (es) Compuesto de sales opticamente puras de piridinilmetil, sulfinil, bencimidazol.
ES2118231T3 (es) Composiciones azeotropicas ternarias.
CO4950531A1 (es) Analogos de la vitamina d3 composciiones farmaceuticas que los contienen
ES2143487T3 (es) 1,2,4-oxadiazolil-fenoxialquilisoxazoles y su empleo como agentes antivirales.
DE60101348D1 (de) Fluor enthaltende Dien-Verbindung, deren Herstellung sowie deren Polymer
HUP0001090A2 (hu) Szulfonil-karbamid és adjuváns alapú szilárd keverékek
PT1427280E (pt) Novos compostos
CO5550416A2 (es) Compuestos surfactantes y usos de los mismos
NO20034667L (no) Arylsulfonamider som antivirale midler
MX9100607A (es) Compuesto triciclico novedoso o sales del mismo,metodo para producir el mismo y agente antimicrobiano que lo contiene
FR2459279B1 (fr) Composition detergente liquide contenant un systeme adjuvant actif
EP0982281A4 (en) Fluorinated, saturated hydrocarbons
ES2115220T3 (es) Nuevo uso de compuestos bis-heterociclicos como agentes antiinflamatorios y composiciones farmaceuticas de los mismos.
AR035110A1 (es) Compuesto derivado de piperazina, uso del mismo para la preparacion de una composicion farmaceutica, composicion farmaceutica que lo comprende y procedimiento para la preparacion de dicho compuesto
ES2171722T3 (es) Nuevos derivados de la 5-o-desosaminil-6-o-metil-eritronolida a, su procedimiento de preparacion y su aplicacion a la preparacion de productos biologicamente activos.
ATE294777T1 (de) Fluorierte ionische polymere
EA200100364A1 (ru) Тиазолилциннамонитрилы и средства борьбы с вредителями

Legal Events

Date Code Title Description
FC Application refused